Although the promoter region of CDKN1A, the gene encoding p21cip1/waf1, is usually not methylated in acute myeloid leukemia (AML), decitabine is capable of inducing its re-expression via induction of DNA damage and activation of the ATM/p53 pathway [14]. The gene discussed is TP53; the disease is acute myeloid leukemia.